TrialHuman vaccines & immunotherapeutics2023

Immunogenicity and safety of a new hexavalent rotavirus vaccine in Chinese infants: A randomized, double-blind, placebo-controlled phase 2 clinical trial.

Zhi-Wei Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.